- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Market Size, 2025
$0.94 BnMarket Estimate, 2026
$0.98 BnMarket Forecast, 2034
$1.32 BnCAGR, 2026–2034
3.80%Global D-Mannose Market Size, Growth, Trends & Forecast (2026–2034)
The size of the global D-mannose market was calculated to be USD 0.94 billion in 2025, is anticipated to reach USD 0.98 billion in 2026, and is projected to scale up to USD 1.32 billion by 2034, registering a compound annual growth rate (CAGR) of 3.80% during the forecast period from 2026 to 2034. Driven by rising consumer demand for low-glycemic functional foods, increasing applications in urinary tract infection (UTI) prevention, and expanding adoption of natural dietary supplements, the market continues to expand steadily worldwide.
Key Executive Metrics (At-a-Glance)
- 2025 Base Valuation: USD 0.94 Billion
- 2026 Current Valuation: USD 0.98 Billion
- 2034 Forecast Valuation: USD 1.32 Billion
- Compound Annual Growth Rate (CAGR): 3.80% (2026–2034)
- Dominant Form Segment: Capsule (holding a leading market share due to superior chemical stability and an effective oxygen barrier)
- Fastest-Growing Form Segment: Capsule (projected to record high momentum via consumer preference for precise dosage and convenience)
- Dominant Application Segment: Dietary Supplement (leading market share driven by growing health-conscious demand for low-calorie products and urinary health solutions)
- Fastest-Growing Application Segment: Food Additives (expanding rapidly through innovative product formulations in developed regions)
- Dominant Region: North America (accounting for the largest market share anchored by high awareness of low-calorie products and specialized UTI preventatives)
- Fastest-Growing Region: Asia-Pacific (projected to record the highest regional growth driven by animal feed expansion and natural-flavored supplements)
Core Market Drivers
- Glycemic Control Benefits: D-mannose suppresses insulin responses, lowers the glycemic index, and is absorbed slowly without storing heavily in the liver compared to glucose.
- Preventive Healthcare Demand: Rising preference for natural, non-antibiotic alternatives to prevent and manage urinary tract infections (UTIs) and metabolic disorders.
- Clean-Label & Millennial Shifts: Growing consumer focus on health-friendly functional foods, natural flavors, and nutritional supplements without flavor sacrifices.
Primary Market Restraints & Challenges
- Side Effects of Long-Term Use: Potential gastrointestinal discomfort, including bloating, loose stools, and diarrhea resulting from prolonged supplement consumption.
- Formulation Constraints: Processing limitations and strict stability requirements when blending monosaccharides into mass-market commercial foods.
Global D-Mannose Market Segmentation Breakdown
| Segment Category | Leading Sub-Segment (2025 Base) | Fastest-Growing Sub-Segment (2026–2034) |
|---|---|---|
| By Form | Capsule (leading format with high chemical stability and low moisture content) | Capsule (expanding via consumer demand for precise dosing and convenience) |
| By Application | Dietary Supplements (largest share driven by low-calorie and urinary wellness products) | Food Additives (fastest growth due to increased functional food launches in developed markets) |
| By Region | North America (market leader supported by high adoption of health supplements and low-calorie trends) | Asia-Pacific (fastest-growing region propelled by animal feed demand and younger health-conscious demographics) |
Major Industry Players Profiled
Key enterprises shaping the competitive global D-mannose market include Danisco (Dupont), Nature Supplies, Douglas Laboratories, Sweet Cures, Hebei Huaxu, Huachang, Hubei Widely, Specom Biochemical, Amresco LLC, Ferro Pfanstiehl Laboratories, Inc., Hanseler AG, Kyowa Hakko Kirin Co. Ltd., and Jarrow Formulas Inc.
Download Free Sample Report
Global D-Mannose Market Size
The size of the global D-mannose market was calculated to be USD 0.94 billion in 2025 and is anticipated to be worth USD 1.32 billion by 2034 from USD 0.98 billion In 2026, growing at a CAGR of 3.80% during the forecast period.
D-mannose is a type of sugar that can be found in a variety of fruits. It also occurs naturally in some cells of the human body. D-mannose is also known as calbinose, D-mannose, mannose, or semi-nose. Some fruits and vegetables contain D-mannose. Cranberries (and cranberry juice), apples, oranges, peaches, broccoli, and green beans are among them. D-mannose is primarily used to treat carbohydrate-deficient glycoprotein syndrome, an inherited metabolic disorder, and to prevent urinary tract infections (UTIs). It is primarily filtered and flushed out of the body by the kidneys.
MARKET DRIVERS
D-mannose monosaccharides are a better alternative to natural sugars in a variety of functional foods and beverages because they significantly suppress the insulin response and reduce their effect on blood sugar levels. Also, unlike glucose, it is not stored in the liver and is absorbed more slowly in the gastrointestinal tract, lowering the glycaemic index and driving the growth of the D-mannose market.
In addition, as consumers become more committed to a healthy diet, major players are launching apples, oranges, and other natural flavors of D-mannose monosaccharides. Millennials are shifting to nutritious and health-friendly products without sacrificing taste, driving the growth of the D-mannose market. The use of D-mannose (pyranose/furanose) in dietary supplements continues to drive the growth of the D-mannose market.
MARKET RESTRAINTS
D-mannose is used to treat carbohydrate-deficient glycoprotein syndrome, urinary tract infections, and kidney infections. However, the side effects of long-term use of D-mannose monosaccharide supplements such as bloating, loose stools, and diarrhea are one of the major factors presumed to slow the growth of the mannose (D-mannose) market.
Additionally, new product launches, mergers and acquisitions, joint ventures, and geographic expansion are key strategies pursued by players in the Mannose (D-Mannose) market. Leading companies in this market include NOW Health Group Inc., GNC Holdings, Inc., Bio-Tech Pharmacal, Vibrant Health, Nestle Health Science, DuPont de NemoursInc.c, NutriSciences Innovations LLC, Jarrow FormulaInc.nc, Hänseler AG, and Pfanstiehl Inc.
REPORT COVERAGE
| REPORT METRIC | DETAILS |
| Market Size Available | 2025 to 2034 |
| Base Year | 2025 |
| Forecast Period | 2026 to 2034 |
| CAGR | 3.8% |
| Segments Covered | By Form, Application, and Region |
| Various Analyses Covered | Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overviof on Investment Opportunities |
| Regions Covered | North America, Europe, APAC, Latin America, Middle East & Africa |
| Market Leaders Profiled | Danisco, Nature Supplies, Douglas Laboratories, Sweet Cures, Hebei Huaxu, Huachang, Hubei Widely, Specom Biochemical, Amresco LLC, Ferro Pfanstiehl Laboratories, Inc, Hanseler AG, Kyowa Hakko Kirin Co Ltd, Jarrow Formulas Inc, and Others. |
SEGMENTAL ANALYSIS
Global D-Mannose Market Analysis By Form
- Capsule
- Powder
- Tablet
The D-mannose market can be further divided into capsules, powders, and tablets based on foam. The capsule segment has the largest share in 2021 and is estimated to be the fastest growing segment with a CAGR of over the period 2022-2027. This growth stems from its ability to be an effective oxygen barrier with excellent chemical stability. D-mannose capsules are stable at low humidity and have low water content and low static charge. Increasing consumer preference for capsule-based formulations is driving the growth of the D-mannose market. The tablet segment held the second largest share in 2021, owing to its longer shelf life. D-Mannose monosaccharide tablets contain additives that hold the pill together and improve the taste, texture, and appearance, which is propelling the growth of the D-Mannose Market.
Global D-Mannose Market Analysis By Application
- Food Additives
- Anti-Inflammatory
- Animal Feed
- Dietary Supplement
- Others
The D-Mannose Market, based on the Application, can be further segmented into Food Additives, Anti-Inflammatory, Animal Feed, Dietary Supplement, and Others. The Dietary Supplement segment held the largest share in 2021 owing to factors such as an increase in the demand for low-calorie products and growing demand for D-Mannose monosaccharides among health-conscious customers. The growing demand for D-Mannose (pyranose/furanose) in the consumption of dietary supplements as a convenient and effective solution for maintaining urinary tract health is driving the growth of the D-Mannose Market. Food additives are considered to be the fastest growing segment with a CAGR of over the period 2022-2027. This growth is due to the increased launch of food additives in developed countries. Adding D-mannose monosaccharides to food additives alleviates the symptoms of cat cystitis, supports bladder health, and promotes the growth of the D-mannose market.
REGIONAL ANALYSIS
North America held the largest market share of 37.8% of the overall market in 2022. Growth in this segment is driven by factors such as increased demand for low-calorie products, increased product launches by major companies, and increased demand for D-mannose monosaccharides in food additives. The growing demand for D-mannose (pyranose/furanose) in various applications to treat and prevent urinary tract infections (UTIs) is driving the growth of the D-Mannose Market. The Asia Pacific region is expected to be the fastest-growing segment from 2022 to 2027. Growth in this segment includes increased demand for D-mannose monosaccharides in the animal feed industry, increased customer propensity for natural-flavored dietary supplements, and increased awareness of nutritious products among younger customers.
KEY MARKET PLAYERS
Major Key Players in the Global D-Mannose Market are Danisco (Dupont), Nature Supplies, Douglas Laboratories, Sweet Cures, Hebei Huaxu, Huachang, Hubei Widely, Specom Biochemical, Amresco LLC, Ferro Pfanstiehl Laboratories, Inc, Hanseler AG, Kyowa Hakko Kirin Co Ltd, And Jarrow Formulas Inc
RECENT HAPPENINGS IN THE MARKET
- DuPont Introduces HOWARU® Calm, a New Probiotic Shown to Reduce Perceived Stress - launched HOWARU® Calm, a probiotic aimed at helping dietary supplement manufacturers decrease the cycle of consumer stress.
- According to surveys, 65 percent of adults worldwide report that stress is a regular part of their daily lives. Prolonged stress can have a negative impact on mood, sleep, and digestive health.
- Natrol and Jarrow Formulas Come Together Under New Company as Vytalogy Wellness - Natrol and Jarrow Formulas, two leading vitamin and supplement brands, officially came together as a new company, Vytalogy Wellness (Vytalogy). Natrol and Jarrow Formulas will remain the brand names for the products that customers have come to know and love.